Sitemap
April 17, 2016 Articles
Filter by Available Specialty
- AACR presents several scientific awards
- Addition of nivolumab to ipilimumab extends survival in BRAF wild-type melanoma
- CD4 T-cell immunotherapy that targets MAGE-A3 shows promise in metastatic cancer
- Centric Medical announces full market launch of stand-alone wedge fixation system for foot, ankle
- DMR System receives CE Mark for treatment of diabetes, NAFLD
- Emricasan effective in high MELD setting
- HBV more prevalent among refugees in Germany vs. general population
- MAGELLAN-I: Novel regimen yields strong results in experienced patients with RAVs
- Nivolumab increases 5-year survival in metastatic melanoma
- Papillary muscle surgery may benefit patients with ischemic mitral regurgitation
- Pembrolizumab superior to ipilimumab for PD-L1–positive melanoma
- Strensiq improves bone healing in children with hypophosphatasia
- Study sheds light on RAVs in treatment-naive, experienced patients
- UC San Diego researchers awarded $9.5 million to investigate antibiotic resistance
- VIDEO: Anti–PD-1 immunotherapy confers ‘encouraging’ survival benefit in metastatic melanoma
- VIDEO: Liquid biopsies valuable but will not eliminate need to assess tumor tissue
- VIDEO: Melanoma research must determine how to maximize efficacy, minimize toxicity
- VIDEO: Surgeon discusses complicated case of combined cataract, glaucoma surgery